GW
Goldenwell Biotech, Inc.
GWLL · OTC
$0.69 +0.00% (+$0.00)
Market Cap $68.3M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/S 2,943.75x
PEG N/A
P/E N/A
Growth
0 /100
Declining Rev. growth 79.43%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 409.10%
Gross margin 107.83%
FCF margin 111.64%
Quality
69 /100
Excellent Asset turnover 0.64x
ROIC 144.34%
ROA 725.93%
Debt
42 /100
Moderate Int. coverage -60.43x
Current ratio 1.98x
Debt/Assets N/A
Stability
1 /100
Unstable EPS volatility 421.11%
Beta 4.60x
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na GWLL
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Shuang Liu
Employees
3
Headquarters
Solon